Mycobacterial Antimicrobial Resistance

  • Peter D. O. Davies
  • Richard Cooke
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)


Mycobacterium Tuberculosis Directly Observe Therapy Antituberculosis Drug British Thoracic Society Rifampicin Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abate, G., (2002), Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation. Ethiopian Med J, 40, 79–86.Google Scholar
  2. Abe, C. and Abu, A.K.K., (2002), Status of antituberculosis drug resistance in Saudi Arabia 1979–98. East Mediterranean Hlth J, 8, 664–670.Google Scholar
  3. Aberg, J.A., Wong, M.K., Flamm, R., Notario, G.F. and Jacobson, M.A., (2001), Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. HIV Clin Trials, 2, 453–459.PubMedGoogle Scholar
  4. Adegbola, R.A., Hill, P., Baldeh, I., Out, J., Sarr, R., Sillah, J., Lienhardt, C., Corrah, T., Manneh, K., Drobniewski, F. and McAdam, K.P.J.W., (2003), Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis, 7, 390–393.PubMedGoogle Scholar
  5. Al-Marri, M.R., (2001), Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Int J Tuberc Lung Dis, 5, 1116–1121.PubMedGoogle Scholar
  6. American Thoracic Society, (1994), Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med, 149, 1359–1374.Google Scholar
  7. American Thoracic Society, (1997), Diagnosis and treatment of diseases caused by nontuberculous mycobacteria. Am J Respir Crit Care Med, 156, S1–S25.Google Scholar
  8. Augustynowicz, K.E., Zwolska, Z., Jaworski, A., Kostrzewa, E. and Klatt, M., (2003), Drug-resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis, 7, 645–651.Google Scholar
  9. Balabanova, Y., Ruddy, M., Hubb, J., Yates, M., Malomanova, N., Fedorin, I. and Drobniewski, F., (2005), Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis 24, 136–139.PubMedGoogle Scholar
  10. Banks, J. and Campbell, I., (2003), Environmental mycobacteria. In P.D.O. Davies, editor, Clinical Tuberculosis. London, Arnold, pp. 439–448.Google Scholar
  11. Baylan, O., Kisa, O., Albay, A. and Doganci, L., (2004), Evaluation of a new automated, rapid colormetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int J Tuberc Lung Dis, 8, 772–777.PubMedGoogle Scholar
  12. Breathnach, A.S., de Ruiter, A., Holdsworth, G.M., Bateman, N.T., O’Sullivan, D.G., Rees, P.J., Snashall, D., Milburn, H.J., Peters, B.S., Watson, J., Drobniewski, F.A. and French, G.L., (1998), An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect, 92, 111–117.Google Scholar
  13. Brennan, P.J. and Draper, P., (1994), Ultrastructure of Mycobacterium tuberculosis: In Bloom, E.R., editor, Tuberculosis: Pathogenesis, Protection and Control. Washington, DC, American Society for Microbiology, pp. 271–284.Google Scholar
  14. Butt, T., Ahmad, R.N., Kazmi, S.Y. and Rafi, N., (2004), Multi-drug resistant tuberculosis in Northern Pakistan. J Pak Med Assoc, 54, 469–472.PubMedGoogle Scholar
  15. Caminero, J.A., (2005), Management of multidrug resistant tuberculosis and patients in retreatment. Eur Respir J, 25, 928–936.PubMedGoogle Scholar
  16. Centres for Disease Control and Prevention, (1992), Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system: New York, 1991. MMWR Morb Mortal Wkly Rep, 41 (28), 507–509.Google Scholar
  17. Centres for Disease Control and Prevention, (1993), Outbreak of multidrug-resistant tuberculosis at a hospital: New York City, 1991. MMWR Morb Mortal Wkly Rep, 42 (22), 427, 433–434.Google Scholar
  18. Centres for Disease Control and Prevention, (2005), National plan for reliable tuberculosis laboratory services using a systems approach: recommendations from CDC and the Association of Public Health Laboratories. Task Force on Tuberculosis Laboratory Services. MMWR Morb Mortal Wkly Rep, 54 [RR-6], 1–12.Google Scholar
  19. Chan, E.D., Laurel, V., Strand, M.J., Chan, J.F., Huynh, M.L.N., Goble, M. and Iseman, M.D., (2004), Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med, 169, 1103–1109.PubMedGoogle Scholar
  20. Chiang, Y.C., Hsu, C.J., Huang, M.R., Lin, P.T. and Luh, K.T., (2004), Antituberculosis drug resistance among retreatment tuberculosis patients in a referral centre in Taipei. J Formosa Med Assoc, 103, 411–541.Google Scholar
  21. Condos, R., Rom, W.N. and Schluger, N.W., (1997), Treatment of multidrug-resistant pulmonary tuberculosis with interferon-g via aerosol. Lancet, 349, 1513–1515.PubMedGoogle Scholar
  22. Conover, C., Ridzon, R., Valway, S., Schoenstadt, L., McAuley, J., Onorato, I. and Paul, W., (2001), Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis, 1, 59–64.Google Scholar
  23. Coronado, V.G., Beck-Sague, C.M., Hutton, M.D., Davis, B.J., Nicholas, P., Villareal, C., Woodley, C.L., Kilburn, J.O., Crawford, J.T. and Frieden, T.R., (1993), Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis, 1684, 1052–1055.Google Scholar
  24. Cox, H.S., Orozco, J.D., Male, R., Ruesch, G.S., Falzon, D., Small, I., Doshetov, D., Kebede, Y. and Aziz, M., (2004), Multidrug-resistant tuberculosis in central Asia. Emerg Infect Dis, 10, 865–872.PubMedGoogle Scholar
  25. Craft, J.C., Notario, G.F., Grosset, J.H. and Heifets, L.B., (1998), Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS. Clin Infect Dis, 27, 807–812.PubMedGoogle Scholar
  26. Cynamon, M.H., Klemens, S.P., Sharpe, C.A. and Chase, S., (1999), Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. Antimicrob. Agents Chemother, 43, 1189–1191.PubMedGoogle Scholar
  27. Daikos, G.L., Cleary, T., Rodriguez, A. and Fischl, M.A., (2003), Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis, 7, 394–398.PubMedGoogle Scholar
  28. David, H.L., Jahan, M.T., Jumin, J., Grandry, J. and Lehman, E.H., (1978), Numerical taxonomy analysis of Mycobacterium africanum. Int J Syst Bacteriol, 28, 464–472.Google Scholar
  29. Davies, L. and Davies, P.D.O., (1995), Non-tuberculosis mycobacterial infections: no fire without a smoke. Am J Respir Crit Care Med, 151, A7I5.Google Scholar
  30. Davies, P.D.O., (1994), Infection with Mycobacterium kansasii. (Editorial). Thorax, 49, 435–436.PubMedGoogle Scholar
  31. Deivanayagam, C.N., Rajasekaran, S., Venkatesan, S., Mahilmaran, A., Ahmed, P.R.K., Annadurai, S., Kumar, S., Chandrasekar, C., Ravichandran, N. and Pencillaiah, R., (2002), Ind J Chest Dis Allied Sci, 44, 237–242.Google Scholar
  32. De Riemer, K., Garcia, G.L., Bobadilla-del-Valle, M., Palacios, M.M., Martinez, G.A., Small, P.M., Sifuentes, O.J. and Ponce-de-Leon, A., (2005), Does DOTS work in populations with drug-resistant tuberculosis? Lancet, 365, 1239–1245.Google Scholar
  33. Dewan, P., Sosnovskaja, A, Thomsen, V., Cicenaite, J., Laserson, K., Johansen, I., Davidaviciene, D. and Wells, C., (2005), High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. Int J Tuberc Lung Dis, 9, 170–174.PubMedGoogle Scholar
  34. Drobniewski, F.A., (1997), Is death inevitable with multiresistant TB plus HIV infection? Lancet, 349, 71–72.PubMedGoogle Scholar
  35. Drobniewski, F.A., Caws, M., Gibson, A. and Young, D., (2003), Modern laboratory diagnosis of tuberculosis. Lancet Infect Dis, 3, 141–147.PubMedGoogle Scholar
  36. Drobniewski, F.A., Watterson, S.A., Wilson, S.M. and Harris, G.S., (2000), A clinical, microbiological and economic analysis of national service for the rapid diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol, 49, 271–278.PubMedGoogle Scholar
  37. Durek, C., Richter, E., Basteck, A., Rüsch-Gerdes, R., Gerdes, J., Jocham, D. and Bohle, A., (2001), The fate of bacillus Calmette-Guerin after intravesical instillation. J Urol, 165, 1765–1768.PubMedGoogle Scholar
  38. Dye, (2002), J. Infect Dis, 185, 1197–1202.Google Scholar
  39. Evans, S.A., Colville, A., Evans, A.L., Crisp A.L. and Johnston, I.D.A., (1996), Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax, 51, 1248–1252.PubMedGoogle Scholar
  40. Friedland, J.S., (2004), Tuberculosis. In J. Cohen, W.G. Powderly, editors, Infectious Diseases, 2nd Edition, Volume 1. New York, Mosby, pp. 401–418.Google Scholar
  41. Gale, E.F., Cundliff, E., Reynolds, P.E., Richmond, M.H., Waring, M.J., (1981), The Molecular Basis of Antibiotic Action, 2nd Edition. New York, Wiley.Google Scholar
  42. Giosue, S., Casarini, M., Ameglio, F., Zangrilli, P., Palla, M., Attieri, A.M. and Bisette, A., (2000), Aerosolized interferon-alpha treatment in patients with multidrug-resistant pulmonary tuberculosis. Eur Cytokine Netw, 11, 99–104.PubMedGoogle Scholar
  43. Goble, M., Iseman, M.D., Madsen, L.A., Waite, D., Ackerson, L. and Horsburgh, C.R, (1993), Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med, 328, 527–532.PubMedGoogle Scholar
  44. Grosskinsky, C.M., Jacobs, W.R., Jr, Clark-Curtiss, J.E. and Bloom, B.R., (1989), Genetic relationships among Mycobacterium tuberculosis and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun, 57, 1535–1541.PubMedGoogle Scholar
  45. Hannan, M.M., Peres, H., Maltez, F., Hayward, A.C., Machado, J., Morgado, A., Proenca, R., Nelson, M.R., Bico, J., Young, D.B. and Gazzard, B.S., (2002), Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect, 72, 91–97.Google Scholar
  46. Hayward, A.C., Bennett, D.E., Herbert. J. and Watson, J.M., (1996), Risk factors for drug resistance in patients with tuberculosis in England and Wales 1993–4. Thorax, 51(Suppl 3), S32.Google Scholar
  47. Hillemann, D., Weizenegger, M., Kubica, T., Richter, E. and Niemann, S., (2000), Use of genotype DNA MTBDR assay for the rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect, 2, 659–669.Google Scholar
  48. Hillemann, D., Weizenegger, M., Kubica, T., Richter, E. and Niemann, S., (2005), Use of genotype MTB DR assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol, 43, 3699–3703.PubMedGoogle Scholar
  49. Hirano, K., Wada, M. and Aoyagi, T., (2001), Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997. Int J Tuberc Lung Dis, 5, 46–52.PubMedGoogle Scholar
  50. Holland, S.M., Eisenstein, E.M., Kuhns, D.B., Turner, M.L., Fleisher, T.A., Strober, W. and Gallin, J.I., (1994), Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon-gamma: a preliminary report. N Engl J Med, 330, 1348–1355.PubMedGoogle Scholar
  51. Hong Kong Chest Service/British Medical Research Council, (1981), First report: controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet, 1, 171–174.Google Scholar
  52. Hong Kong Chest Service/British Medical Research Council, (1982), Second report: controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months. The results up to 24 months. Tubercle, 63, 89–98.Google Scholar
  53. Hong Kong Chest Service/British Medical Research Council, (1987), Five year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis, 136, 1339–1342.Google Scholar
  54. Hong Kong Chest Service/British Medical Research Council, (1991), Controlled trial of 2, 4 and 6 months of pyrazinamide in 6 month, three-times weekly regimens for smear-positive tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide. Results at 30 months. Am Rev Respir Dis, 143, 700–706.Google Scholar
  55. Iseman, M., (1993), Treatment of multidrug resistant tuberculosis. N Engl J Med, 329, 784–790.PubMedGoogle Scholar
  56. Jacobs, W.R., Jr, Barletta, R.G., Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G.J., Hatfull, G.F. and Bloom, B.R., (1993), Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reported phages, Science, 260, 819–822.PubMedGoogle Scholar
  57. Johansen, I.S., Lundgern, B., Sosnovskaja, A. and Thomsen, V.O., (2003), Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low-and high-incidence countries by line probe assay. J Clin Microbiol, 41, 4454–4456.PubMedGoogle Scholar
  58. Johansen, I.S., Thomsen, V.O., Marjamäkj, M., Sosnovskaja, A. and Lungern, B., (2004), Rapid, automated, non-radiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line anti-tuberculous drugs used in standard short-course chemotherapy. Diagn Microbiol Infect Dis, 50, 103–107.PubMedGoogle Scholar
  59. Johnson, B.J., Bekker, L.G., Rickman, Brown, S., Lesser, M., Ress, S., Willcox, P., Steyn, L. and Kaplan, G., (1997), rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tuber Lung Dis, 78, 195–203.PubMedGoogle Scholar
  60. Joint Tuberculosis Committee of the British Thoracic Society, (1998), Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax, 53, 536–548.Google Scholar
  61. Joint Tuberculosis Committee of the British Thoracic Society, (2000), Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax, 55, 887–901.Google Scholar
  62. Juréen, P., Warngren, J. and Hoffner, S.E., (2004), Evaluation of the line probe assay (Li PA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis, 84, 311–316.PubMedGoogle Scholar
  63. Kam, K.M. and Yip, C.W., (2004), Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995–2002, after the implementation of DOTS-plus. Int J Tuberc Lung Dis, 8, 760–766.PubMedGoogle Scholar
  64. Kartaloglu, Z., Bozkanat, E., Ozturkeri, H., Okutan, O. and Ilvan, A., (2002), Primary antituberculosis drug resistance at Turkish military chest diseases hospital in Istanbul. Med Princ Pract, 11, 202–205.PubMedGoogle Scholar
  65. Kassa, K.E., Bobossi, S.G., Takeng, E.C., Nambea, K.T.B., Yapou, F. and Talarmin, A., (2004), Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis, 8, 574–578.Google Scholar
  66. Kelly, P.M., Scott, L. and Krause, V.L., (2002), Tuberculosis in East Timorese refugees: implications for health care needs in East Timor. Int J Tuberc Lung Dis, 6, 980–987.PubMedGoogle Scholar
  67. Kim, H.C., Goo, M.J., Lee, H.J., Park, H.S., Park, M.C., Kim, T.J. and Im, J.G., (2004), Multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in human immunodeficiency virus-negative patients: computed tomography features. J Comput Assist Tomogr, 28, 366–371.PubMedGoogle Scholar
  68. Kimerling, M.E., Schuchter, J, Chanthol, E., Kunthy, T., Stuer, F., Glaziou, P. and Ee, O., (2002), Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis, 6, 988–994.PubMedGoogle Scholar
  69. Kisa, O., Abley, A., Bedir, O., Baylon, O. and Doganci, L., (2003), Evaluation of FAST Plaque to TB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis, 7, 284–288.PubMedGoogle Scholar
  70. Kochi, A., Vareldzis, B. and Styblo, K., (1993), Multidrug-resistant tuberculosis and its control. Res Microb, 144, 104–110.Google Scholar
  71. Konno, K., Feldmann, F.M. and McDermott, W., (1967), Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis, 95, 461–469.PubMedGoogle Scholar
  72. Krishnamurthy, A., Rodriques, C. and Mehta, A.P., (2002), Rapid detection of rifampicin resistance in M. tuberculosis by phage assay. Ind J Med Microbiol, 20, 211–214.Google Scholar
  73. Lee, J. and Chang, J.H., (2001), Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Kor J Int Med, 16, 173–179.Google Scholar
  74. Lefford, M.J., (1966), The ethionamide sensitivity of British pre-treatment strains of Mycobacterium tuberculosis. Tubercle Lond, 47, 198–206.Google Scholar
  75. Leimane, V., Riekstina, V., Holtz, T.H., Zarovska, E., Skripconoka, V., Thorpe, L.E., Laserson, K.F. and Wells, C.D., (2005), Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet, 365, 318–326.PubMedGoogle Scholar
  76. Levin, M.E. and Hatfull, G.F., (1993), Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol, 8, 277–285.PubMedGoogle Scholar
  77. Levy-Frebault, V.V. and Portaels, F., (1992), Proposed minimal standards for the genus Mycobacteria and the description of new slowly growing Mycobacterium species. Int J Syst Bacteriol, 42, 315–323.PubMedGoogle Scholar
  78. Li, J., Burzynski, J.N., Lee, Y.A., Berg, D., Driver, R.C., Ridzon, R. and Munsiff, S.S., (2004), Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients. Chest, 126, 1770–1776.PubMedGoogle Scholar
  79. Lin, J., Sattar, A.N. and Puckree, T., (2004), An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. Int J Tuberc Lung Dis, 8, 568–573.PubMedGoogle Scholar
  80. Lockman, S., Kruuner, A., Binkin, N., Levina, K., Wang, Y., Danilovitsh, M., Hoffner, S. and Tappero, J., (2003), Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Clin Infect Dis, 32, 373–380.Google Scholar
  81. Mahmoudi, A. and Iseman, M.D., (1993), Pitfalls in the care of patients with tuberculosis. JAMA, 270, 65–68.PubMedGoogle Scholar
  82. Maloney, S.A., Pearson, M.L., Gordon, M.T., Del Castillo, R., Boyle, J.F. and Jarvis, W.R., (1995), Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med, 122, 90–95.PubMedGoogle Scholar
  83. Marín, M., de Viedma, D.G., Ruiz-Serrano, M.J. and Bouza, E., (2004), Rapid detection of multiple rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real time PCR. Antimicrob Agents Chemother, 48, 4293–4300.PubMedGoogle Scholar
  84. Mortilla, H. J., Soini, H., Vyshnevskiy, B. I., Otten, T.F., Vasilyef, A.V., Huovinen, P. and Viljanen, M.K., (1998), Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis, 30, 129–132.Google Scholar
  85. McClure, W.R. and Cech, C.L., (1978), On the mechanism of rifampicin inhibition if RNA synthesis. J Biol Chem, 253, 8949–8956.PubMedGoogle Scholar
  86. Mitchell, I., Wendon, J., Fi, H.S. and Williams, R., (1995), Anti-tuberculous therapy and acute liver failure. Lancet, 345, 555–556.PubMedGoogle Scholar
  87. Mitchison, D.A. and Nunn, A.J., (1986), Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis, 133, 423–430.Google Scholar
  88. Migliori, G.B., Raviglione, M.C., Schaberg, T., Davies, P.D.O., Zellweger, J.P., Grzemska, M., Mihaescu, T., Clancy, L. and Casali, L., (1999), Tuberculosis management in Europe. Eur Respir J, 14, 978–992.PubMedGoogle Scholar
  89. Mokrousov, L.O., Narvskaya, T., Otten, T., Limeshenke, E., Steklova, L. and Vyshnevskiy, B., (2002), High prevalence of katG Ser 315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia 1996 to 2001. Antimicrob Agents Chemother, 46, 1417–1424.PubMedGoogle Scholar
  90. Moro, M.L., Errante, I., Infuso, A., Sodano, L., Gori, A., Orcese, C.A., Salamina, G., D’Amico, C., Besozzi, G. and Caggese, L., (2000), Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy. Int J Tuberc Lung Dis, 41, 61–68.Google Scholar
  91. Moro, M.L., Gori, A., Errante, I., Infuso, A., Franzetti, F., Sodano, L. and Iemoli, E., (1998), An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multidrug-Resistant Tuberculosis Outbreak Study Group. AIDS, 129, 1095–1102.Google Scholar
  92. Mukherjee, J.S., Joseph, J.K., Rich, M.L., Shin, S.S., Furin, J.J., Seung, K.J., Sloutsky, A., Socci, A.R., Vanderwarker, C., Vasquez, L., Palacios, E., Guerra, D., Viru, F.A., Farmer, P. and Del-Castillo, H.E., (2003), Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis, 7, 637–644.PubMedGoogle Scholar
  93. Oleksijew, A., Meulbroek, J., Ewing, P., Jarvis, K., Mitten, M., Paige, L., Tovcimak, A., Nukkula, M., Chu, D. and Alder, J.D., (1998), In vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strains. Antimicrob Agents Chemother, 42, 2674–2677.PubMedGoogle Scholar
  94. Pablos-Mendez, A. and Lessnau, K., (2000), Clinical mismanagement and other factors producing antituberculosis drug resistance. In I. Bastian and F. Portaels, editors, Multidrug-resistant Tuberculosis. Dordrecht, Kluwer, pp. 59–76.Google Scholar
  95. Palmero, D., Ritacco, V., Ambroggi, M., Marcela, N., Barrera, L., Capone, L., Dambrosi, A., di-Lonardo, M., Isola, N., Poggi, S., Vescovo, M. and Abbate, E., (2003), Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg Inf Dis, 9, 965–969.Google Scholar
  96. Park, S.K., Lee, C.M., Heu, J.P. and Song, S.D., (2002), A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 6, 143–149.PubMedGoogle Scholar
  97. Petrie, J.G., Barnwell, E. and Grimshaw, J., (1995), on behalf of the Scottish InterCollegiate Guidelines Network. Clinical Guidelines: Criteria for Appraisal for National Use. Edinburgh: Royal College of Physicians.Google Scholar
  98. PHLS (1999) Tuberculosis Update. Public Health Laboratory Service Communicable Disease Surveillance Centre. December 1999.Google Scholar
  99. Piatek, A.S., Telenti, A., Murray, M.R., El-Hajj, H. and Jacobs, W.R., Jr., (2000), Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother, 44, 103–110.PubMedGoogle Scholar
  100. Pierce, M., Crampton, S., Henry, D., Heifets, L., LaMarca, A., Montecalvo, M., Wormser, G.P., Jablonowski, H., Jemsek, J., Cynamon, M., Yangco, B.G., Notario, G. and Craft, J.C., (1996), A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med, 335, 384–391.PubMedGoogle Scholar
  101. Pitchenik, A.E., Burr, J., Laufer, M., Miller, G., Cacciatore, R., Bigler, W.J., Witte, J.J. and Cleary, T., (1990), Outbreaks of drug-resistant tuberculosis at AIDS centre. Lancet, 336, 440–441.PubMedGoogle Scholar
  102. Pomerantz, B.J., Cleveland, J.C., Olson, H.K. and Pomerantz, M., (2001), Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg, 121, 448–453.PubMedGoogle Scholar
  103. Punnotok, J., Shaffer, N., Naiwatanakul, T., Pumprueg, U., Subhannachart, P., Ittiravivongs, A., Chuchotthaworn, C., Ponglertnapagorn, P., Chantharojwong, N., Young, N.L., Limpakarnjanarat, K. and Mastro, T.D., (2000), Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. Int J Tuberc Lung Dis, 4, 537–543.PubMedGoogle Scholar
  104. Quy, H.T.W., Lan, N.T.N., Borgdorff, M.W., Grosset, J., Linh, P.D., Tung, L.B., van-Soolingen, D., Raviglione, M., Co, N.V. and Broekmans, J., (2003), Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis, 7, 631–636.PubMedGoogle Scholar
  105. Ramaswamy, S. and Musser, J.M., (1998), Molecular genetic-basis of antimicrobial agent resistance in Mycobacterium tuberculosis, 1998 update. Tuber Lung Dis, 79, 3–29.PubMedGoogle Scholar
  106. Romano, G., Michell, P., Pacilio, C. and Giordano, A., (2000), Latest development in gene transfer technology, achievements, perspectives and controversies over therapeutic applications. Stem Cells, 18, 19–39.PubMedGoogle Scholar
  107. Rosner, J.L., (1993), Susceptibilities of oxyR regulon mutants of Escherchia coli and Salmonella typhimurium to isoniazid. Antimicrob Agents Chemother, 37, 2251–2253PubMedGoogle Scholar
  108. Rossau, R., Traore, H., De Beenhouwer, H., Mijs, W., Jannes, G., de Rijk, P. and Portaels, F., (1997), Evaluation of the INNO-LIPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother, 41, 2093–2098.PubMedGoogle Scholar
  109. Ruddy, M., Balabanova, Y., Graham, C., Fedorin, I., Malomanova, N., Elisarova, E., Kuznetznov, S., Gusarova, G., Zakharova, S., Melentyev, A., Krukova, E., Golishevskaya, V., Erokhin, V., Dorozhkova, I. and Drobniewski, F., (2005), Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax, 60, 130–135.PubMedGoogle Scholar
  110. Reechaipichitkul, W., (2002), Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Pub Hlth, 33, 570–574.Google Scholar
  111. Robert, J., Trystram, D., Truffot, P.C. and Jarlier, V., (2003), Multidrug-resistant tuberculosis, eight years of surveillance in France. Eur Respir J, 22, 833–837.PubMedGoogle Scholar
  112. Salaniponi, F.M., Nyirenda, T.E., Kemp, J.R., Squire, S.B., Godfrey-Faussett, P. and Harries, A.D., (2003), Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis, 7, 948–952.PubMedGoogle Scholar
  113. Scarparo, C., Ricordi, P., Ruggiero, G. and Piccoli, P., (2004), Evaluation of the fully Automated BACTEC MGIT 960 system for testing susceptibility to Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampicin and ethembutol and comparison with the Radiometric BACTEC 460 TB method. J Clin Microbiol, 42, 1109–1114.PubMedGoogle Scholar
  114. Schaaf, H.S., Shean, K. and Donald, P.R., (2003), Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child, 88, 1106–1111.PubMedGoogle Scholar
  115. Schneider, E., Laserson, K.F., Wells, C.D. and Moore, M., (2004), Tuberculosis along the United States–Mexico border, 1993–2001. Rev Panam Salud Pub, 16, 23–34.Google Scholar
  116. Schraufnagel, D.E., (1999), Tuberculosis treatment for the beginning of the next century. Int J Tuberc Lung Dis, 3, 651–662.PubMedGoogle Scholar
  117. Senaratne, W.V., (2004), Outcome of treatment of multidrug resistant tuberculosis. Ceylon Med J, 49, 86–87.PubMedGoogle Scholar
  118. Shafer, R.W., Small, P.M., Larkin, C., Singh, S.P., Kelly, P., Sierra, M.F., Schoolnik, G. and Chirgwin, K.D., (1995), Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. J Infect Dis, 171, 170–176.PubMedGoogle Scholar
  119. Shafran, S.D., (1998), Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. Int J Infect Dis, 3, 39–47.PubMedGoogle Scholar
  120. Shafran, S.D., Talbot, J.A., Chomyc, S., Davison, E., Singer, J., Phillips, P., Salit, I., Walmsley, S.L., Fong, I.W., Gill, M.J., Rachlis, A.R. and Lalonde, R.G., (1998), Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. Clin Infect Dis, 27, 1401–1405.PubMedGoogle Scholar
  121. Shah, A.R., Agarwal, S.K. and Shah, K.V., (2002), Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc Lung Dis, 6, 1098–1010.PubMedGoogle Scholar
  122. Shin, S., Furin, J., Bayona, J., Mate, K., Kim, J.Y. and Farmer, P., (2004), Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med, 59, 1529–1539.PubMedGoogle Scholar
  123. Shiraishi, Y., Nakajima, Y., Katsuragi, N., Kurai, M. and Takahashi, N., (2004), Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J Thorac Cardovasc Surg, 128, 523–528.Google Scholar
  124. Slayden, R.A., Barry, C.E., 3rd, (2000), The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect, 2, 659–669.PubMedGoogle Scholar
  125. Small, P.M., Shafer, R.W., Hopewell, P.C., Singh, S.P., Murphy, M.J., Desmond, E., Sierra, M.F. and Schoolnik, G.K., (1993), Exogenous re-infection with multi-drug resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med, 328, 1137–1144.PubMedGoogle Scholar
  126. Sreevatson, S., Pan, X., Zhang, Y., Deretic, V. and Musser, J.M., (1997), Analysis of the oxyR–ahpC region in isoniazid-resistant and susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Antimicrob Agents Chemother, 41, 600–606.Google Scholar
  127. Stanford, J.L., Stanford, C.A., Grange, J.M., Lan, N.N. and Etemadi, A., (2001), Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multidrug-resistant pulmonary tuberculosis? Respir Med, 95, 444–447.PubMedGoogle Scholar
  128. Stover, C.K., Warrener, P., Van Devanter, D.R., Sherman, D.R., Arain, T.M., Langhorne, M.H., Anderson, S.W., Towell, J.A., Yuan, Y., McMurray, D.N., Kreiswirth, B.N., Barry, C.E. and Baker, W.R., (2000), A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 405, 962–966.PubMedGoogle Scholar
  129. Stroud, L.A., Tokars, J.I., Grieco, M.H., Crawford, J.T., Culver, D.H., Edlin, B.R., Sordillo, E.M., Woodley, C.L., Gilligan, M.E. and Schneider, N., (1995), Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol, 3, 141–147.Google Scholar
  130. Suarez, S., O’Hara, P., Kazantseva, M., Newcomer, C.E., Hopfer, R., McMurray, D.N., Hickey, A.J., (2001), Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother, 48, 431–434.PubMedGoogle Scholar
  131. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society, (2000), Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax, 55, 210–218.Google Scholar
  132. Syre, H., Phyu, S., Sandven, P., Bjorvatn, B. and Grewd, H.M.S., (2003), Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampicin in liquid cultures. J Clin Microbiol, 41, 5173–5177.PubMedGoogle Scholar
  133. Talbot, E.A., Kenyon, T.A., Mwasekaga, M.J., Moeti, T.L., Mallon, V. and Binkin, N.J., (2003), Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis, 7, 72–77.PubMedGoogle Scholar
  134. Telenti, A., Honoré, N., Bernasconi, J., March, J., Ortega, A., Heym, B., Takiff, H.E. and Cole, S.T., (1997), Genotyping assessment of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol, 35, 719–723.PubMedGoogle Scholar
  135. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. and Bodmer, T., (1993), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647–650.PubMedGoogle Scholar
  136. Telzak, E.E., Sepowitz, K., Alpert, P., Mannheimer, S., Medard, F., el-Sadr, W., Blum, S., Gagliardi, A., Salomon, N. and Turett, G., (1995), Multidrug-resistant TB in patients without HIV infection. N Engl J Med, 333, 907–911.PubMedGoogle Scholar
  137. The Inter Departmental Working Group on Tuberculosis, (1998), The Prevention and Control of Tuberculosis in the United Kingdom: UK Guidance on the Prevention and Control of 1) HIV-Related Tuberculosis and 2) Drug Resistant, Including Multiple Drug Resistant, Tuberculosis. Department of Health, The Scottish Office, The Welsh Office, September 1998.Google Scholar
  138. Timperi, R, Han, L.L., Sloutsky, A, Becerra, M.C., Nardell, E.A., Salazar, J.J. and Smith, F.M.C., (2005), Drug resistance profiles of Mycobacterium tuberculosis isolates: five years’ experience and insight into treatment strategies for MDR-TB in Lima, Peru. Int J Tuberc Lung Dis, 9, 175–180.PubMedGoogle Scholar
  139. Torosyan, A.A., Gurova, A.A. and Mandulova, P.V., (2000), A fifteen-month survey of directly observed therapy—short course and antibiotic drug resistance in the region of Plovdiv. Folia Med, 42, 10–14.Google Scholar
  140. Toungoussova, O.S., Nizovtseva, N.I., Mariandyshev, A.O., Caugant, D.A., Sandven, P. and Bjune, G., (2004), Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999. Eur J Clin Microbiol Infect Dis, 23, 174–179.PubMedGoogle Scholar
  141. Trakada, G., Tsiamita, M. and Spiropoulos, K., (2004), Drug-resistance of Mycobacterium tuberculosis in Patras, Greece. Monaldi Arch Chest Dis, 61, 65–70.PubMedGoogle Scholar
  142. Tsai, M.S., Chong, I.W., Hwang, J.J., Wang, T.H. and Huang, S.M., (2004), A subset of clinical status of pulmonary tuberculosis in Southern Taiwan. Southeast Asian J Trop Med Pub Hlth, 35, 136–139.Google Scholar
  143. Tsogt, G., Naranbat, N., Buyankhisig, B., Batkhuyag, B., Fujiki, A. and Mori, T., (2002), The nationwide tuberculosis drug resistance survey in Mongolia, 1999. Int J Tuberc Lung Dis, 6, 289–294.PubMedGoogle Scholar
  144. Tupasi, T.E., Quelapio, M.I.D., Orillaza, R.B., Alcantar, C., Mira, N.R.C., Abeleda, M.R., Belen, V.T., Arnisto, N.M., Rivera, A.B., Grimaldo, E.R., Derilo, J.O., Dimarucut, W., Arabit, M. and Urboda, D., (2003), DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tuberculosis, 83, 52–58.PubMedGoogle Scholar
  145. Uplekar, M.W. and Shepard, D.S., (1991), Treatment of tuberculosis by private practitioners in India. Tubercle, 72, 284–290.PubMedGoogle Scholar
  146. Vanacore, P., Koehler, B., Carbonara, S., Zacchini, F., Bassetti, D., Antonucci, G., Ippolito, G. and Girardi, E., (2004), Drug-resistant tuberculosis in HIV-infected persons: Italy 1999–2000. Infection, 32, 328–332.PubMedGoogle Scholar
  147. van Soolingen, D., Hoogenboezem, T., de Haas P.E.W., Hermans, P.W., Koedam, M.A., Teppema, K.S., Brennan, P.J., Besra, G.S., Portaels, F., Top, J., Schouls, L.M. and Embden, J.D., (1997), A novel pathogen taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol, 47, 1236–1245.PubMedGoogle Scholar
  148. van Soolingen, D., von der Zanden, A.G.M., de Haas, P.E.W., Noordhoek, G.T., Kiers, A., Foudraine, N.A., Portaels, F., Kolk, A.H.J., Kremer, K. and van Embden, J.D.A., (1998), Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol, 36, 1840–1845.PubMedGoogle Scholar
  149. Wada, T., Maeda, S., Tamaru, A., Shigeyoshi, L., Hase, A. and Kobayashi, K., (2004), Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol, 42, 5277–5285.PubMedGoogle Scholar
  150. World Health Organization, (1997), Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, WHO. WHO/TB/97.220.Google Scholar
  151. World Health Organisation Tuberculosis Unit, (1991), Division of Communicable Diseases. Guidelines for Tuberculosis Treatment in Adults and Children in National Tuberculosis Programmes. Geneva, WHO. WHO/TB/91, pp 1–61.Google Scholar
  152. World Health Organization, (2004), Anti-tuberculosis Drug Resistance in the World. Report No.3. Geneva, WHO.Google Scholar
  153. Yam, W.E., Tem, C.M., Leung, C.C., Tong, L., Chan, K. H., Leung, E.T.Y., Wong, K.C., Yew, W.W., Seto, W.H., Yuen, K. and Ho, P.L., (2004), Direct detection of rifampicin-resistant Mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J Clin Microbiol, 42, 4438–4443.PubMedGoogle Scholar
  154. Yew, W.W., (2001), Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives. Clin Chim Acta, 313, 31–36.PubMedGoogle Scholar
  155. Zaman, K., Rahim, Z., Yunus, M., Arifeen, S., Baqui, A., Sack, D., Hossain, S., Banu, S., Islam, A.M., Ahmed, J., Breiman, R. and Black, R., (2005), Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scand J Infect Dis, 37, 21–26.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Peter D. O. Davies
  • Richard Cooke

There are no affiliations available

Personalised recommendations